Stool-based testing has poor sensitivity and low negative predictive value for colorectal cancer screening in patients with cystic fibrosis.

HHS terminates COVID-19 Emergency Use Authorizations for drugs, biologics, and devices, establishing transition timelines toward traditional FDA pathways.

Anxiety and depression are common in patients with idiopathic pulmonary fibrosis and are significantly affected by the diagnostic criteria used.

The PRILD scoring system can help in the systematic assessment of thoracic involvement in rheumatologic-related ILD.

Test your knowledge on changing approaches to managing patients with asthma outlined in the 2026 GINA asthma update.

Individuals who survive hematologic cancers are at high risk for subsequently developing cardiovascular disease.

Among healthy adults receiving the JN.1- or KP.2-adapted mRNA seasonal COVID-19 vaccine, neutralizing antibody responses were similar.

Patients with cystic fibrosis often reduce or discontinue respiratory cotherapies after starting CFTR modulators without affecting clinical status.

Even after the introduction of ETI for cystic fibrosis, habit continues to have a key role in adherence to inhaled medicines in patients with CF.

Some combination blood pressure-lowering therapies are better tolerated than monotherapies, and AEs may lead to discontinuation of therapy.

Nintedanib showed comparable efficacy in reducing lung function decline as well as a similar safety profile in patients with ...

Sugammadex lowers the risk for postoperative pulmonary complications vs neostigmine after major abdominal or thoracic surgery in older adults.